Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,481.20
(
-1.01%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
2.39%
)
Bitcoin
70,558.01
(
0.94%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 17488

Thursday, 10/27/2005 11:26:49 AM

Thursday, October 27, 2005 11:26:49 AM

Post# of 257264
Erbitux 3Q05 factoids

17% of sales were in combination with both Avastin and chemo;
68% of sales were in combination with chemo (but not Avastin);
15% of sales were in monotherapy.

79% of sales were in colorectal cancer (the rest in H&N, pancreatic, and lung).

Penetration in colorectal cancer:
1st-line: 4%; 2nd-line: 14%; 3rd-line 30%.

Source: IMCL CC

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today